Actively Recruiting

Age: 18Years +
All Genders
NCT07038083

REal-world Data of CARdiometabolic ProtEcTion

Led by Sun Yat-sen University · Updated on 2025-06-26

40000

Participants Needed

1

Research Sites

1565 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a single-center, historical prospective cohort study including patients diagnosed with metabolic cardiovascular disease, including hypertension, diabetes, obesity, dyslipidemia, hyperuricemia. The primary outcome of the study is all-cause death and cardiovascular death, and the secondary outcome is major adverse cardiovascular events. We aim to measure associations of established or suspected cardiometabolic disease (CMD) risk factors and cardiovascular disease outcomes in a real-world representative cohort.

CONDITIONS

Official Title

REal-world Data of CARdiometabolic ProtEcTion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years old
  • Patients clinically diagnosed with metabolic cardiovascular disease, including hypertension, diabetes, obesity, dyslipidemia, or hyperuricemia
  • Hypertension or normal high blood pressure confirmed by three clinic measurements with systolic blood pressure 20 mmHg or higher and/or diastolic blood pressure 80 mmHg or higher
  • Diabetes diagnosed by typical symptoms and any of the following: random blood glucose 11.1 mmol/L, fasting blood glucose 7.0 mmol/L, 2-hour postprandial blood glucose 11.1 mmol/L, or HbA1c 6.5%
  • Obesity or overweight defined as body mass index (BMI) 24 kg/m�b2
  • Dyslipidemia with at least one abnormal lipid indicator: total cholesterol 6.2 mmol/L, LDL-C 4.1 mmol/L, HDL-C below 1.0 mmol/L, triglycerides 2.3 mmol/L, or lipoprotein(a) 30 mg/dL
  • Hyperuricemia with fasting blood uric acid levels above 420 bcmol/L (7 mg/dL) in men or above 360 bcmol/L (6 mg/dL) in women on two different days
Not Eligible

You will not qualify if you...

  • Patients unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital of Sun Yat-sen Univerity

Guangzhou, Guangdong, China, 510000

Actively Recruiting

Loading map...

Research Team

X

Xiaodong Zhuang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here